X0306 4 2019-11-12 1 0001563577 Galera Therapeutics, Inc. GRTX 0001793311 Blackstone Clarus GP L.P. C/O THE BLACKSTONE GROUP INC. 345 PARK AVENUE NEW YORK NY 10154 0 0 1 0 0001793316 Blackstone Clarus GP L.L.C. C/O THE BLACKSTONE GROUP INC. 345 PARK AVENUE NEW YORK NY 10154 0 0 1 0 0001484870 Blackstone Holdings II L.P. C/O THE BLACKSTONE GROUP INC. 345 PARK AVENUE NEW YORK NY 10154 0 0 1 0 0001464695 Blackstone Holdings I/II GP L.L.C. C/O THE BLACKSTONE GROUP INC. 345 PARK AVENUE NEW YORK NY 10154 0 0 1 0 0001393818 Blackstone Group Inc 345 PARK AVENUE NEW YORK NY 10154 0 0 1 0 0001404071 Blackstone Group Management L.L.C. C/O THE BLACKSTONE GROUP INC. 345 PARK AVENUE NEW YORK NY 10154 0 0 1 0 0001070844 SCHWARZMAN STEPHEN A C/O THE BLACKSTONE GROUP INC. 345 PARK AVENUE NEW YORK NY 10154 0 0 1 0 Common Stock 2019-11-12 4 C 0 461769 A 461769 I See Footnotes Common Stock 2019-11-12 4 C 0 301001 A 301001 I See Footnotes Common Stock 2019-11-12 4 C 0 555193 A 555193 I See Footnotes Common Stock 2019-11-12 4 C 0 111021 A 111021 I See Footnotes Common Stock 2019-11-12 4 P 0 80786 12.00 A 542555 I See Footnotes Common Stock 2019-11-12 4 P 0 52660 12.00 A 353661 I See Footnotes Common Stock 2019-11-12 4 P 0 97131 12.00 A 652324 I See Footnotes Common Stock 2019-11-12 4 P 0 19423 12.00 A 130444 I See Footnotes Series C Redeemable Convertible Preferred Stock 2019-11-12 4 C 0 2334966 0.00 D Common Stock 461769 0 I See Footnotes Series C Redeemable Convertible Preferred Stock 2019-11-12 4 C 0 1552035 0.00 D Common Stock 301001 0 I See Footnotes Series C Redeemable Convertible Preferred Stock 2019-11-12 4 C 0 2807372 0.00 D Common Stock 555193 0 I See Footnotes Series C Redeemable Convertible Preferred Stock 2019-11-12 4 C 0 561385 0.00 D Common Stock 111021 0 I See Footnotes These shares of the Issuer's Series C redeemable convertible preferred stock ("Redeemable Convertible Preferred Stock") are convertible into shares of the Issuer's common stock ("Common Stock") on a 0.197763-for-one basis at the holder's election and have no expiration date. The Redeemable Convertible Preferred Stock will automatically convert into Common Stock upon the closing of the Issuer's initial public offering. These securities are held directly by Clarus IV-A, L.P. These securities are held directly by Clarus IV-B, L.P. These securities are held directly by Clarus IV-C, L.P. These securities are held directly by Clarus IV-D, L.P. (collectively, with Clarus IV-A, L.P., Clarus IV-B, L.P. and Clarus IV-C, L.P., the "Clarus Funds"). The general partner of each of the Clarus Funds is Clarus IV GP, L.P. The general partner of Clarus IV GP, L.P. is Blackstone Clarus GP L.P. The general partner of Blackstone Clarus GP L.P. is Blackstone Clarus GP L.L.C. The sole member of Blackstone Clarus GP L.L.C. is Blackstone Holdings II L.P. The general partner of Blackstone Holdings II L.P. is Blackstone Holdings I/II GP L.L.C. The sole member of Blackstone Holdings I/II GP L.L.C. is The Blackstone Group Inc. The sole holder of the Class C common stock of The Blackstone Group Inc. is Blackstone Group Management L.L.C. Blackstone Group Management L.L.C. is wholly-owned by Blackstone's senior managing directors and controlled by its founder, Stephen A. Schwarzman. Due to the limitations of the electronic filing system certain Reporting Persons are filing a separate Form 4. Information with respect to each of the Reporting Persons is given solely by such Reporting Person, and no Reporting Person has responsibility for the accuracy or completeness of information supplied by another Reporting Person. Each of such Reporting Persons may be deemed to beneficially own the securities reported herein directly or indirectly controlled by it or him, but each (other than the Clarus Funds to the extent of their direct holdings) disclaims beneficial ownership of such securities, except to the extent of such Reporting Person's pecuniary interest therein. The filing of this statement shall not be deemed to be an admission that, for purposes of Section 16 of the Securities Exchange Act of 1934 or otherwise, the Reporting Persons are the beneficial owners of any securities reported herein. Due to the number of shares of Common Stock outstanding after the closing of the Issuer's initial public offering on November 12, 2019, the Reporting Persons are no longer 10% beneficial owners. BLACKSTONE CLARUS GP L.P., By: Blackstone Clarus GP L.L.C., its general partner, By: /s/ John G. Finley, Name: John G. Finley, Title: Chief Legal Officer 2019-11-14 BLACKSTONE CLARUS GP L.L.C., By: /s/ John G. Finley, Name: John G. Finley, Title: Chief Legal Officer 2019-11-14 BLACKSTONE HOLDINGS II L.P., By: Blackstone Holdings I/II GP L.L.C., its general partner, By: /s/ John G. Finley, Name: John G. Finley, Title: Chief Legal Officer 2019-11-14 BLACKSTONE HOLDINGS I/II GP L.L.C., By: /s/ John G. Finley, Name: John G. Finley, Title: Chief Legal Officer 2019-11-14 THE BLACKSTONE GROUP INC., By: /s/ John G. Finley, Name: John G. Finley, Title: Chief Legal Officer 2019-11-14 BLACKSTONE GROUP MANAGEMENT L.L.C., By: /s/ John G. Finley, Name: John G. Finley, Title: Chief Legal Officer 2019-11-14 /s/ Stephen A. Schwarzman 2019-11-14